These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32779823)

  • 1. Should we screen patients with hematologic malignancies for COVID-19?
    Rassy E; Khoury-Abboud RM; Ibrahim N; Assi T; Samra B; Hanna C; Karak FE; Ghosn M
    Hematol Oncol; 2020 Dec; 38(5):648-653. PubMed ID: 32779823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective: SARS-CoV-2, COVID-19 and Haematologists.
    Gale RP
    Acta Haematol; 2021; 144(2):117-121. PubMed ID: 32375142
    [No Abstract]   [Full Text] [Related]  

  • 3. Weathering the storm: COVID-19 infection in patients with hematological malignancies.
    Wang LQ; Tan Su Yin E; Wei GQ; Hu YX; Nagler A; Huang H
    J Zhejiang Univ Sci B; 2020 Dec.; 21(12):921-939. PubMed ID: 33843158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review.
    SeyedAlinaghi S; Karimi A; Mirzapour P; Salmani R; Razi A; Mojdeganlou H; Mojdeganlou P; Qodrati M; Jashaninejad R; Paranjkhoo P; Dadras O; Zarezadeh B; Afsahi AM; Afzalian A; Varshochi S; Mehraeen E; Afsahi G
    Infect Disord Drug Targets; 2023; 23(7):29-38. PubMed ID: 37138433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in hematology-oncology patients.
    Bird PW; Badhwar V; Kennedy B; Ladani S; Tang JW
    J Med Virol; 2021 Jul; 93(7):4585-4591. PubMed ID: 33595119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
    Wood WA; Neuberg DS; Thompson JC; Tallman MS; Sekeres MA; Sehn LH; Anderson KC; Goldberg AD; Pennell NA; Niemeyer CM; Tucker E; Hewitt K; Plovnick RM; Hicks LK
    Blood Adv; 2020 Dec; 4(23):5966-5975. PubMed ID: 33278301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.
    Niu A; Ning B; Socola F; Safah H; Reynolds T; Ibrahim M; Safa F; Alfonso T; Luk A; Mushatt DM; Hu T; Saba NS
    Leuk Res; 2021 Jul; 106():106582. PubMed ID: 33933714
    [No Abstract]   [Full Text] [Related]  

  • 8. ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.
    Oncologist; 2021 Feb; 26 Suppl 1(Suppl 1):S17-S18. PubMed ID: 33368829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematology and oncology clinical care during the coronavirus disease 2019 pandemic.
    Shah MA; Emlen MF; Shore T; Mayer S; Leonard JP; Rossi A; Martin P; Ritchie E; Niesvizky R; Pastore R; Cigler T; De Sancho M; Scheff R; Van Besien K; Roboz G; Nanus D; Goldstein P; Scrimenti L; Hidalgo M
    CA Cancer J Clin; 2020 Sep; 70(5):349-354. PubMed ID: 32662880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.
    Modemann F; Niederwieser C; Weisel K; Bokemeyer C; Fiedler W; Ghandili S
    Leuk Lymphoma; 2022 Mar; 63(3):664-671. PubMed ID: 34668809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
    Booth S; Curley HM; Varnai C; Arnold R; Lee LYW; Campton NA; Cook G; Purshouse K; Aries J; Innes A; Cook LB; Tomkins O; Oram HS; Tilby M; Kulasekararaj A; Wrench D; Dolly S; Newsom-Davies T; Pettengell R; Gault A; Moody S; Mittal S; Altohami M; Tillet T; Illingworth J; Mukherjee L; Apperly J; Ashcroft J; Rabin N; Carmichael J; Cazier JB; Kerr R; Middleton G; Collins GP; Palles C;
    Br J Haematol; 2022 Feb; 196(4):892-901. PubMed ID: 34761389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the COVID-19 Pandemic Reshaped the Management of Leukemia and Affected Patient Outcomes.
    Sharafeldin N; Bates B; Vachhani P
    Curr Treat Options Oncol; 2022 May; 23(5):688-702. PubMed ID: 35334062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing patients with hematological malignancies during COVID-19 pandemic.
    Sahu KK; Cerny J
    Expert Rev Hematol; 2020 Aug; 13(8):787-793. PubMed ID: 32580592
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.
    Assi T; Samra B; Dercle L; Rassy E; Kattan J; Ghosn M; Houot R; Ammari S
    Front Oncol; 2020; 10():1267. PubMed ID: 32719749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
    Malek AE
    Br J Cancer; 2021 Mar; 124(7):1183. PubMed ID: 33398065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside.
    Laracy JC; Kamboj M; Vardhana SA
    Curr Opin Infect Dis; 2022 Aug; 35(4):271-279. PubMed ID: 35849516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy.
    Ibrahim M; Vegel A; Niu A; Panse K; Chen R; Safah H; Socola F; Luk A; Saba NS
    Leuk Res; 2021 Feb; 101():106514. PubMed ID: 33524639
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of hematologic malignancies during the COVID-19 pandemic.
    Hus I; Salomon-Perzyński A; Tomasiewicz K; Robak T
    Expert Opin Pharmacother; 2021 Apr; 22(5):565-582. PubMed ID: 33342308
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic.
    Seval GC; Topçuoğlu P; Demirer T
    Turk J Med Sci; 2021 Dec; 51(6):2799-2809. PubMed ID: 33705648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.